Related Experiment Video

Updated: May 28, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy

Ross Vlahos1, John Stambas, Stavros Selemidis

  • 1Respiratory Research Group, Department of Pharmacology, The University of Melbourne, Victoria, Australia.

Trends in Pharmacological Sciences
|October 4, 2011
PubMed

Insights

Targeting NADPH oxidase 2 (Nox2) to suppress superoxide production significantly reduces influenza A virus lung injury and replication. This approach offers a promising strategy to combat influenza A, complementing existing treatments.

Area of Science:

  • Virology
  • Immunology
  • Pathology

Background:

  • Influenza A virus causes millions of deaths globally, straining healthcare systems.
  • Current treatments face challenges due to antiviral resistance and the need for strain-specific vaccines.
  • Reactive oxygen species (ROS), like superoxide, are part of the host defense but can be harmful in excess during infection.

Purpose of the Study:

  • To investigate the role of NADPH oxidase 2 (Nox2) in influenza A virus-induced lung injury.
  • To determine if inhibiting Nox2 can mitigate lung damage and viral replication.
  • To explore Nox2 inhibitors as a potential therapeutic strategy for influenza A.

Main Methods:

  • Studied the impact of suppressing superoxide production by targeting Nox2 in mammalian inflammatory cells.
  • Assessed the effects on influenza A virus-induced lung injury and viral replication.
  • Evaluated the efficacy irrespective of the infecting influenza A virus strain.

Main Results:

  • Suppression of superoxide production via Nox2 inhibition significantly alleviated influenza A virus-induced lung injury.
  • Inhibiting Nox2 also markedly reduced influenza A virus replication.
  • These beneficial effects were observed regardless of the specific influenza A virus strain used.

Conclusions:

  • Excessive superoxide production, mediated by Nox2, exacerbates influenza A virus lung disease.
  • Targeting Nox2 offers a potential therapeutic avenue for influenza A virus infections.
  • Nox2 inhibitors could be a valuable addition to current antiviral and vaccine strategies.

More Related Videos

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...